menu search

ABC / Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. Read More
Posted: Aug 29 2023, 14:17
Author Name: Zacks Investment Research
Views: 101820

ABC News  

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

By Zacks Investment Research
August 29, 2023

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. more_horizontal

Walgreens Sells AmerisourceBergen Shares To Raise $1.85 Billion To Pay Down Debt And Accelerate Health Strategy

By Forbes
August 3, 2023

Walgreens Sells AmerisourceBergen Shares To Raise $1.85 Billion To Pay Down Debt And Accelerate Health Strategy

Walgreens Boots Alliance has sold shares of AmerisourceBergen for initial proceeds of $2.85 billion, which will be used to accelerate the drugstore gi more_horizontal

Walgreens sells $1.85 bln of AmerisourceBergen shares, further cutting stake

By Reuters
August 3, 2023

Walgreens sells $1.85 bln of AmerisourceBergen shares, further cutting stake

Walgreens Boots Alliance has sold some AmerisourceBergen Corp's shares for proceeds of about $1.85 billion, the U.S. drugstore chain said on Thursday, more_horizontal

Walgreens Boots Alliance sells shares of AmerisourceBergen for $1.85 billion

By Market Watch
August 3, 2023

Walgreens Boots Alliance sells shares of AmerisourceBergen for $1.85 billion

Drugstore chain Walgreens Boots Alliance Inc. WBA, -1.17% on Thursday said it sold shares of drug distributor AmerisourceBergen Corp. ABC, -0.04% for more_horizontal

AmerisourceBergen (ABC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

By Zacks Investment Research
August 2, 2023

AmerisourceBergen (ABC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for AmerisourceBergen (ABC) give a sense of how its business performed in the quarter ended June 2023, it might be worth more_horizontal

AmerisourceBergen forecasts upbeat annual profit as weight-loss drugs lift results

By Reuters
August 2, 2023

AmerisourceBergen forecasts upbeat annual profit as weight-loss drugs lift results

Drug distributor AmerisourceBergen raised its full-year profit forecast on Wednesday, as soaring demand for weight-loss drugs and specialty medicines more_horizontal

AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)

By Seeking Alpha
July 28, 2023

AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)

AmerisourceBergen has seen a 3x return on investment in the past 3 years, outperforming the market. I think it's a very solid company in pharma and he more_horizontal

Is a Beat Likely for AmerisourceBergen (ABC) in Q3 Earnings?

By Zacks Investment Research
July 26, 2023

Is a Beat Likely for AmerisourceBergen (ABC) in Q3 Earnings?

AmerisourceBergen's (ABC) fiscal third-quarter 2023 results are likely to reflect solid performance at the U.S. Healthcare Solutions segment. more_horizontal


Search within

Pages Search Results: